Foley Hoag advised Daewoong Pharmaceutical on the deal. South Korea’s Daewoong Pharmaceutical (“Daewoong”) secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based multinational company focused...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here